|
Volumn 28, Issue 1, 2010, Pages 3-4
|
As Genzyme flounders, competitors and activist investors swoop in
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOTECHNOLOGY;
CONTAMINATION;
ENZYME SYNTHESIS;
FABRY DISEASE;
FOOD AND DRUG ADMINISTRATION;
GAUCHER DISEASE;
NOTE;
PRIORITY JOURNAL;
BIOREACTORS;
DRUG CONTAMINATION;
DRUG INDUSTRY;
ECONOMIC COMPETITION;
HUMANS;
INVESTMENTS;
QUALITY CONTROL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
PLEURONECTOIDEI;
|
EID: 74049089275
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0110-3 Document Type: Note |
Times cited : (15)
|
References (0)
|